The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis

In low- and middle-income countries, treatment of highly selected MDR-TB patients with a standardised 9–12 month regimen leads to 80% or better successful treatment outcomeshttp://bit.ly/384SFpY